Literature DB >> 7004242

Disulfiram distribution and elimination in the rat after oral and intraperitoneal administration.

M D Faiman, L Artman, K Haya.   

Abstract

35S disulfiram (DSF), 7 mg/kg, was administered as a single dose to rats both orally (p.o.) or intraperitoneally (i.p.). The 35S DSF was rapidly absorbed by either route. Kidney, pancreas, liver, and the gastrointestinal tract exhibited the greatest uptake of radioactivity, while the least was found in brain. Preferential tissue uptake was similar with both routes of administration. Seven percent of the dose was excreted in the feces. Approximately 12% of the dose was eliminated by the breath as CS2. The 35S-DSF was rapidly metabolized to the 35S-diethyldithiocarbamate-glucuronide and 35S inorganic sulfate. Approximately 93% of the radioactivity was accounted for 48 hr after p.o. or i.p. 35S administration.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7004242     DOI: 10.1111/j.1530-0277.1980.tb04841.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  6 in total

1.  Disulfiram metabolite S-methyl-N,N-diethylthiocarbamate quantitation in human plasma with reverse phase ultra performance liquid chromatography and mass spectrometry.

Authors:  Jill Hochreiter; Elinore F McCance-Katz; Jill Lapham; Qing Ma; Gene D Morse
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2012-04-01       Impact factor: 3.205

2.  Effects of disulfiram on choice behavior in a rodent gambling task: association with catecholamine levels.

Authors:  Patricia Di Ciano; Daniel F Manvich; Abhiram Pushparaj; Andrew Gappasov; Ellen J Hess; David Weinshenker; Bernard Le Foll
Journal:  Psychopharmacology (Berl)       Date:  2017-10-30       Impact factor: 4.530

3.  Population Pharmacokinetics and Pharmacodynamics of Disulfiram on Inducing Latent HIV-1 Transcription in a Phase IIb Trial.

Authors:  Sulggi A Lee; Julian H Elliott; James McMahon; Wendy Hartogenesis; Namandje N Bumpus; Jeffrey D Lifson; Robert J Gorelick; Peter Bacchetti; Steven G Deeks; Sharon R Lewin; Radojka M Savic
Journal:  Clin Pharmacol Ther       Date:  2018-10-09       Impact factor: 6.875

4.  LC-MS/MS method for the determination of carbamathione in human plasma.

Authors:  Anthonius A M Heemskerk; Leon van Haandel; Joshua M Woods; Elinore F McCance-Katz; Todd D Williams; John F Stobaugh; Morris D Faiman
Journal:  J Pharm Biomed Anal       Date:  2010-11-02       Impact factor: 3.935

5.  Dual-targeting biomimetic delivery for anti-glioma activity via remodeling the tumor microenvironment and directing macrophage-mediated immunotherapy.

Authors:  Pengfei Zhao; Yonghui Wang; Xuejia Kang; Aihua Wu; Weimin Yin; Yisi Tang; Jinyu Wang; Meng Zhang; Yifei Duan; Yongzhuo Huang
Journal:  Chem Sci       Date:  2018-01-31       Impact factor: 9.825

6.  Disulfiram, a drug widely used to control alcoholism, suppresses the self-renewal of glioblastoma and over-rides resistance to temozolomide.

Authors:  Joanna Triscott; Cathy Lee; Kaiji Hu; Abbas Fotovati; Rachel Berns; Mary Pambid; Margaret Luk; Richard E Kast; Esther Kong; Eric Toyota; Stephen Yip; Brian Toyota; Sandra E Dunn
Journal:  Oncotarget       Date:  2012-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.